Core Viewpoint - Jiangsu Fengshan Group Co., Ltd. plans to invest RMB 15 million as a limited partner in the Cixi Zhuoyuan Xingyu No. 2 Venture Capital Fund, accounting for 29.99% of the total investment [2][4]. Group 1: Investment Details - The investment will be made using the company's own funds and does not require board or shareholder approval as it does not meet the criteria for significant asset restructuring [3][5]. - The total capital commitment for the fund is RMB 50.01 million, with Fengshan Group contributing RMB 15 million [21]. Group 2: Fund Management and Structure - The fund will be managed by Guangdong Zhuoyuan Asia Zhongke Venture Capital Co., Ltd., which has a professional investment management team and a normal operating status [7][8]. - The fund's management fee is set at 2% of the paid-in capital annually for four years, totaling 8% for each limited partner [15][23]. Group 3: Investment Strategy and Duration - The fund aims to invest in emerging industries such as information technology, with a total operational period of four years, including a one-year investment period and a three-year exit period [20][24]. - The fund's structure allows for the extension of its operational period by up to one year with unanimous consent from all partners [24]. Group 4: Impact on the Company - The investment is expected to have a minimal impact on the company's daily operations and will not be included in the consolidated financial statements [26]. - The investment aligns with the company's development needs and aims to leverage professional resources for reasonable investment returns [26].

2月2日，A股上市药企白云山（证券代码：600332）发布公告显示，公司参与合作设立的广州广药广开创业投资基金合伙企业（有限合伙）（"广药广开基 金"）已于今年1月完成工商登记、取得营业执照，并在中国证券投资基金业协会完成备案手续。公告同时披露，广药广开基金首期实缴出资合计1.2亿元。 广药广开基金出资方及出资比例为广开基金占50%、广药二期基金占48.75%、广药资本占1.25%。其中，出资占比最多的广开基金为黄埔投资控股（广州） 有限公司和广州金控基金管理有限公司的合资公司。 白云山公告显示，近日该公司接到广药资本的通知，广药广开基金已于2026年1月30日在中国证券投资基金业协会完成备案手续，并取得了《私募投资基金 备案证明》。 根据备案信息，该基金名称为广州广药广开创业投资基金合伙企业（有限合伙），管理人名称为广州广药资本私募基金管理有限公司，托管人名称为招商银 行股份有限公司。 白云山在此次公告中表示，本次投资符合广药二期基金的投资方向，有利于扩大广药二期基金投资规模、分散投资风险及加快投资步伐、提高投资效率，将 加强白云山在创新药、现代中药、高端医疗器械等生物医药前沿领域的布局，通过"投早、投小、 ...

Core Viewpoint - The company Baiyunshan has established a new venture capital fund, Guangzhou Guangyao Guangkai Venture Capital Fund, with a total initial capital contribution of 120 million yuan, aimed at enhancing its investment in innovative pharmaceuticals and medical devices [2][5]. Group 1: Fund Establishment and Registration - Baiyunshan announced the completion of the business registration and acquisition of a business license for the Guangzhou Guangyao Guangkai Venture Capital Fund in January 2026 [2][5]. - The fund has been registered with the Asset Management Association of China and has obtained the Private Investment Fund Registration Certificate [5]. Group 2: Investment Details - The total initial capital contribution for the fund is 120 million yuan, with Baiyunshan's subsidiary contributing 9.75 million yuan [3][6]. - The fund's capital structure includes 50% from Guangkai Fund, 48.75% from Guangyao Phase II Fund, and 1.25% from Guangyao Capital [5]. Group 3: Strategic Implications - The investment aligns with the strategic direction of Guangyao Phase II Fund, aiming to expand investment scale, diversify risks, and accelerate investment pace [5]. - Baiyunshan intends to strengthen its position in cutting-edge biomedicine fields through early-stage investments in promising companies, facilitating technological upgrades and extending its value chain [5]. Group 4: Overall Investment Situation - Baiyunshan's total investment in various private equity funds has reached 587 million yuan, with the largest investment being 390 million yuan in the Guangzhou Guangyao Chuantou Venture Capital Fund [6].

Core Viewpoint - Fengshan Group (603810.SH) has signed a partnership agreement for the Cixi Zhuoyuan Xingyu No. 2 Venture Capital Fund, aiming to optimize its investment return structure and enhance investment management capabilities [1] Group 1 - The company will act as a limited partner, investing 15 million in the fund, which represents 29.99% of the total contributions [1]

Core Viewpoint - The article emphasizes the importance of venture capital and private equity in supporting technological innovation, as highlighted by Xi Jinping's article in the "Qiushi" magazine, which outlines the path for China's financial development and the construction of a financial powerhouse [2]. Group 1: Investment Trends - Private equity funds have been crucial in providing financial support for technological innovation, with 90% of companies listed on the Sci-Tech Innovation Board and the Beijing Stock Exchange being backed by venture capital [3]. - The current trend in the industry is to focus on early-stage, small-scale, long-term investments in hard technology, which has become a mainstream consensus among mother funds and venture capital [3]. Group 2: Early and Small Investments - Angel mother funds have entered a period of rapid growth, with over 30 established in China, totaling more than 800 billion yuan. Many of these funds have a high degree of marketization, with over half allowing a maximum investment ratio of 40% in sub-funds [4]. - Local angel mother funds are increasingly building and improving error tolerance mechanisms, which support early-stage investment institutions and encourage a shift in investment stages [4]. Group 3: Long-term Investment - Many newly established mother funds and direct investment funds now have a duration of 15 to 20 years, showing a growing patience for the investment period of sub-funds, with 53% of new guiding funds allowing sub-fund durations of over 10 years [4]. Group 4: Patient Capital - The concept of "patient capital" has gained consensus in the private equity industry, characterized by long-term support and a high tolerance for risk and failure, which is essential for adapting to the long and uncertain cycles of technological innovation [5]. - Compared to previous investment themes focused on internet and consumer sectors, the current focus is on hard technology, necessitating a longer investment horizon for returns [5]. Group 5: Policy Support - Since 2024, the policy environment for the private equity industry has seen significant improvements, with the government increasingly supporting venture capital through various measures, including the "17 policies for promoting high-quality development of venture capital" [6]. - The government has emphasized the importance of developing angel investment, venture capital, and private equity, aiming to attract more social capital into venture investments [6]. Group 6: Future Outlook - The establishment of the National Venture Capital Guiding Fund, with a registered capital of 10 billion yuan, aims to promote patient capital and long-term investments in the venture capital sector [7]. - The article anticipates that the private equity industry will continue to respond to central government calls by enhancing early, small, long-term, and hard technology investments, thereby playing a crucial role in fostering technological innovation in China [7].

经营范围含以自有资金从事投资活动；自有资金投资的资产管理服务；企业总部管理；企业管理咨询； 创业投资（限投资未上市企业）；物业管理；控股公司服务；股权投资；社会经济咨询服务；技术服 务、技术开发、技术咨询、技术交流、技术转让、技术推广；储能技术服务；风力发电技术服务；资源 再生利用技术研发；量子计算技术服务；物联网技术服务；太阳能发电技术服务；物联网技术研发；智 能输配电及控制设备销售；信息系统集成服务；机械设备研发；科技推广和应用服务；新兴能源技术研 发；合同能源管理；人工智能双创服务平台；新材料技术研发；智能机器人的研发；工程管理服务；工 程造价咨询业务；软件开发；货物进出口；技术进出口；进出口代理；会议及展览服务（出国办展须经 相关部门审批）（除依法须经批准的项目外，凭营业执照依法自主开展经营活动） 企业名称中机轻量（江苏）科技产业投资有限公司法定代表人曹秀萍注册资本5000万人民币国标行业科 学研究和技术服务业>科技推广和应用服务业>技术推广服务地址南京市建邺区江心洲文泰街85号综合 楼四楼8406-1320号企业类型有限责任公司（非自然人投资或控股的法人独资）营业期限2026-1-28至无 固定期限 ...

Group 1: Core Perspectives - The 2026 Hangzhou Municipal People's Congress and Political Consultative Conference highlighted the active role of the legal profession in addressing various societal issues through 37 proposals and suggestions [1] - The proposals focus on legal construction, economic development, social governance, and public welfare, showcasing the social responsibility of the legal industry in Hangzhou [1] Group 2: Protecting People's Livelihood - The Hangzhou government emphasizes high-quality management of public welfare, with legal representatives identifying shortcomings in social governance and proposing solutions [2] - A specific concern raised is the issue of housing, where legal representatives suggest improving system design to resolve conflicts arising from vague contract terms in the real estate sector [2] Group 3: Promoting Industrial Development - The legal representatives are advocating for legislative measures to support industrial innovation, particularly in the artificial intelligence sector, by proposing the "Hangzhou Artificial Intelligence Industry Development Promotion Regulations" [3] - There is a call for legislation to clarify responsibilities and ensure safety in the burgeoning low-altitude economy, which currently lacks unified regulations [3] Group 4: Optimizing Business Environment - Proposals include creating regulations to enhance the entrepreneurial investment environment, focusing on information disclosure and diversified fundraising channels [4] - Suggestions also address the persistent issue of accounts receivable delays affecting private enterprises, advocating for a proactive reporting and transparent regulatory mechanism [4] - The need for improved talent policies to retain high-level professionals in Hangzhou is highlighted, with recommendations for a comprehensive approach to attract and retain talent [4]

Group 1 - The Hubei Enshi Qingjiang Industrial Investment Fund Partnership has been established with a total investment of 1 billion RMB [1] - The fund is managed by Changjiang Growth Capital Investment Co., Ltd., focusing on venture capital, private equity investment, investment management, and asset management activities [1] - The partners of the fund include Enshi Industrial Investment Co., Ltd., Changjiang Growth Capital Investment Co., Ltd., Enshi High-tech Investment Development Group Co., Ltd., and Enshi State-owned Capital Investment Operation Group Co., Ltd. [1]

来源：天眼查 每日｜荐读 热文： 谁押中了沐曦股份？ 荐读： 2025募资市场年度观察：一年聊过239家LP的真实感受 荐读： 2025年IPO退出盘点：哪些GP赚钱了？ 热文： 投资人"忙疯了" 近日，陕西低空航飞产业基金合伙企业（有限合伙）成立，出资额3亿元人民币， 执行事务合伙人 为和翎同行（西安）私募基金有限公司。 经营范围包含创业投资（限投资未上市企业）。股权数 据显示，该企业由 陕西省政府投资引导基金合伙企业（有限合伙）、渭南市工业倍增发展基金 （有限合伙）、和翎同行（西安）私募基金有限公司、西安和翎航装投资合伙企业（有限合伙）共 同出资。 ...

（原标题：烽火通信、联通创投等新设创投基金，出资额10亿） 企查查APP显示，近日，湖北烽火创业投资基金合伙企业（有限合伙）成立，出资额10亿元，经营范围 包含：创业投资（限投资未上市企业）；以私募基金从事股权投资、投资管理、资产管理等活动。企查 查股权穿透显示，该企业由烽火通信（600498）、联通战新私募股权投资基金（武汉）合伙企业（有限 合伙）等共同出资。 ...